185212-90-2

Upstream product

• 534-17-8 caesium carbonate 
• 197079-48-4 trans-N-(Benzyloxycarbonyl)-4-hydroxy-L-proline 
• 74-88-4 methyl iodide 

Downstream Products

• 77871-02-4 ester methylique de la N-(benzyloxycarbonyl)-O-(2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl)-L-hydroxyproline 
• 77871-02-4 ester methylique de la N-(benzyloxycarbonyl)-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-L-hydroxyproline 
• 77871-02-4 ester methylique de la N-(benzyloxycarbonyl)-O-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-L-hydroxyproline 
• 77871-02-4 ester methylique de la N-(benzyloxycarbonyl)-O-(2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)-L-hydroxyproline 

Relevant academic research and scientific papers

Nucleic acid-binding oligomers possessing N-branching for therapy and diagnostics

The invention relates to nucleic acid-binding oligomers possessing N-branching of the general formula (I), STR1 and their monomers, where the individual radicals have the meaning given in the description, and to their use as medicaments or as aids in diag

Beta-lactam compounds

A beta-lactam compound of the formula: STR1 or a pharmaceutically acceptable salt thereof, which is useful as an anti-microbial agent or an intermediate in the synthesis of anti-microbial agents.